Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Usha Menon

Showing results (301-310 of 496) with videos related to

Pageof 50
Sort By:
Trials|January 26, 2021
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplarJatinderpal K Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, et al.
BMJ Open|July 27, 2016
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementationDavid Weller, Peter Vedsted, Chantelle Anandan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2014
Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detectionDarragh P O'Brien, Neomal S Sandanayake, Claire Jenkinson, et al.
Plos Medicine|June 3, 2024
Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trialMohammed K Ali, Kavita Singh, Dimple Kondal, et al.
International Journal of Cancer|January 28, 2016
Protein Z: A putative novel biomarker for early detection of ovarian cancerMatthew R Russell, Michael J Walker, Andrew J K Williamson, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
BMJ Open|December 15, 2022
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry dataPeter Vedsted, David Weller, Alina Zalounina Falborg, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
Pageof 50

Showing results (301-310 of 496) with videos related to

Sort By:
Pageof 50
Trials|January 26, 2021
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplarJatinderpal K Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, et al.
BMJ Open|July 27, 2016
An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementationDavid Weller, Peter Vedsted, Chantelle Anandan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2014
Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detectionDarragh P O'Brien, Neomal S Sandanayake, Claire Jenkinson, et al.
Plos Medicine|June 3, 2024
Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trialMohammed K Ali, Kavita Singh, Dimple Kondal, et al.
International Journal of Cancer|January 28, 2016
Protein Z: A putative novel biomarker for early detection of ovarian cancerMatthew R Russell, Michael J Walker, Andrew J K Williamson, et al.
Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.
Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.
Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.
BMJ Open|December 15, 2022
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry dataPeter Vedsted, David Weller, Alina Zalounina Falborg, et al.
International Journal of Molecular Epidemiology and Genetics|May 3, 2011
A polymorphism in the GALNT2 gene and ovarian cancer risk in four population based case-control studiesKathryn L Terry, Allison F Vitonis, Dena Hernandez, et al.
Pageof 50